ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,572.76
      0.10%
      US Tech 100
      19,861.62
      0.08%
      Dow Jones
      39,430.69
      0.14%
      Brent Oil
      85.88
      -0.72%
      Bitcoin
      56,432.19
      1.05%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Antares Pharma Inc (ATRS)

      7. Antares Pharma Inc (ATRS) News

      ATRS

      Antares Pharma (ATRS)

      Antares Pharma Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ATRS
      DateTimeSourceHeadlineSymbolCompany
      06/14/20216:27PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/14/20216:26PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/14/20216:25PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/14/20216:25PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/14/20216:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/14/20216:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/14/20216:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/14/20216:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/10/20215:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/10/20215:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/01/20218:58AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRSAntares Pharma Inc
      05/26/20218:30AMGlobeNewswire Inc.Antares Pharma to Present at the Jefferies Virtual Healthcare ConferenceNASDAQ:ATRSAntares Pharma Inc
      05/06/20214:50PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ATRSAntares Pharma Inc
      05/06/20217:31AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRSAntares Pharma Inc
      05/06/20217:15AMGlobeNewswire Inc.Antares Pharma Appoints Joseph Renda as Senior Vice President of CommercialNASDAQ:ATRSAntares Pharma Inc
      05/06/20217:00AMGlobeNewswire Inc.Antares Pharma Reports First Quarter 2021 Financial and Operating ResultsNASDAQ:ATRSAntares Pharma Inc
      05/03/20215:57PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      05/03/20218:30AMGlobeNewswire Inc.Antares Pharma Announces Poster Presentation at the Pediatric Endocrine Society 2021 Virtual Annual MeetingNASDAQ:ATRSAntares Pharma Inc
      04/28/20218:30AMGlobeNewswire Inc.Antares Pharma to Participate in the 7th Annual Truist Securities 2021 Life Sciences SummitNASDAQ:ATRSAntares Pharma Inc
      04/27/20214:35PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ATRSAntares Pharma Inc
      04/27/20214:33PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ATRSAntares Pharma Inc
      04/27/20218:30AMGlobeNewswire Inc.Antares Pharma to Report First Quarter 2021 Financial and Operating ResultsNASDAQ:ATRSAntares Pharma Inc
      04/26/20218:30AMGlobeNewswire Inc.Antares Pharma Appoints Dr. Peter Richardson as Executive Vice President, Research and Development and Chief Medical OfficerNASDAQ:ATRSAntares Pharma Inc
      03/05/20218:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRSAntares Pharma Inc
      03/03/20216:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      03/03/20216:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      03/02/20214:34PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:ATRSAntares Pharma Inc
      03/02/20217:31AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRSAntares Pharma Inc
      03/02/20217:00AMGlobeNewswire Inc.Antares Pharma Reports Fourth Quarter and Full-Year 2020 Financial and Operating ResultsNASDAQ:ATRSAntares Pharma Inc
      02/23/20218:30AMGlobeNewswire Inc.Antares Pharma to Report Fourth Quarter and Full-Year 2020 Financial and Operating ResultsNASDAQ:ATRSAntares Pharma Inc
       Showing the most relevant articles for your search:NASDAQ:ATRS